Core Viewpoint - The article emphasizes the importance of confirming the sustainability of stock trends for successful short-term investing, highlighting that price movements should be supported by strong fundamentals and positive earnings estimates [1][2]. Group 1: Stock Performance - Catalyst Pharmaceutical (CPRX) has shown a solid price increase of 5.2% over the past 12 weeks, indicating investor confidence in its potential upside [4]. - The stock has also maintained a price increase of 3.8% over the last four weeks, suggesting that the upward trend is still intact [5]. - CPRX is currently trading at 86.8% of its 52-week high-low range, indicating a potential breakout opportunity [5]. Group 2: Fundamental Strength - CPRX holds a Zacks Rank 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimate revisions and EPS surprises [6]. - The stock has an Average Broker Recommendation of 1 (Strong Buy), reflecting high optimism from the brokerage community regarding its near-term price performance [7]. Group 3: Investment Strategy - The article suggests that investors can utilize the "Recent Price Strength" screen to identify stocks like CPRX that are on an uptrend supported by strong fundamentals [3]. - There are over 45 Zacks Premium Screens available for investors to find stocks that align with their personal investing styles [8].
Here's Why Momentum in Catalyst (CPRX) Should Keep going